Alleviating iatrogenic effects of paclitaxel via anti-inflammatory treatment

BACKGROUND: Paclitaxel is touted as an essential medicine due to its extensive use as a chemotherapeutic for various cancers and an antiproliferative agent for restenosis. Due to recent concerns related to long-term mortality, paclitaxel (PTX)-based endovascular therapy is now surrounded by controve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengwei, Lotfollahzadeh, Saran, Elzinad, Nagla, Yang, Xiaosheng, Elsadawi, Murad, Gower, Adam, Belghasem, Mostafa, Shazly, Tarek, Kolachalama, Vijaya B., Chitalia, Vipul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915804/
https://www.ncbi.nlm.nih.gov/pubmed/36778300
http://dx.doi.org/10.21203/rs.3.rs-2487922/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915804/
https://www.ncbi.nlm.nih.gov/pubmed/36778300
http://dx.doi.org/10.21203/rs.3.rs-2487922/v1

Ejemplares similares